Institutional Ownership Avidity Biosciences, Inc. (RNA)
This table provides information about the institutional ownership of Avidity Biosciences, Inc. (RNA). We have compiled data on the 258 institutions that hold shares in the stock, with a total of 108 Million shares, which have been reported (via 13F filing form) to have a value of $3.2 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
11,042,823
shares
|
$360 Million
0.04% of portfolio
|
Q4 2024
Added 3.84%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
9,431,911
shares
|
$308 Million
0.0% of portfolio
|
Q4 2024
Added 2.22%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,622,513
shares
|
$281 Million
0.01% of portfolio
|
Q2 2024
Added 39.84%
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
8,106,097
shares
|
$264 Million
0.04% of portfolio
|
Q4 2024
Added 15.29%
|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
7,932,870
shares
|
$259 Million
3.76% of portfolio
|
Q4 2024
Reduced 2.46%
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
7,500,000
shares
|
$245 Million
3.18% of portfolio
|
Q4 2024
Added 9.09%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
7,053,010
shares
|
$230 Million
0.11% of portfolio
|
Q4 2024
Added 44.05%
|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
6,300,408
shares
|
$205 Million
2.97% of portfolio
|
Q3 2024
Added 16.67%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,602,191
shares
|
$150 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.21%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,807,455
shares
|
$91.6 Million
0.01% of portfolio
|
Q4 2024
Added 8.59%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,751,944
shares
|
$89.7 Million
0.15% of portfolio
|
Q4 2024
Reduced 10.63%
|
|
Casdin Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
2,045,000
shares
|
$66.7 Million
5.12% of portfolio
|
Q4 2024
Reduced 1.91%
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
1,271,891
shares
|
$41.5 Million
0.23% of portfolio
|
Q4 2024
Reduced 17.52%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,228,058
shares
|
$40 Million
0.35% of portfolio
|
Q4 2024
Added 40.84%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,213,776
shares
|
$39.6 Million
0.0% of portfolio
|
Q4 2024
Added 98.58%
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
1,127,295
shares
|
$36.8 Million
1.45% of portfolio
|
Q4 2024
Reduced 21.76%
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
1,112,886
shares
|
$36.3 Million
0.88% of portfolio
|
Q4 2024
Added 6.52%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,079,434
shares
|
$35.2 Million
0.0% of portfolio
|
Q4 2024
Added 11.15%
|
|
Cormorant Asset Management, LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,050,000
shares
|
$34.2 Million
2.41% of portfolio
|
Q3 2024
Added 147.06%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,028,931
shares
|
$33.6 Million
0.01% of portfolio
|
Q4 2024
Added 3.91%
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Feb 12, 2025 Q4 2024 |
1,015,251
shares
|
$33.1 Million
0.05% of portfolio
|
Q4 2024
Reduced 23.62%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
865,820
shares
|
$28.2 Million
0.19% of portfolio
|
Q4 2024
Added 27.67%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
799,028
shares
|
$26.1 Million
0.03% of portfolio
|
Q4 2024
Added 1.6%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
763,055
shares
|
$24.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 12.77%
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
724,787
shares
|
$23.6 Million
0.0% of portfolio
|
Q4 2024
New holding
|